MAPKAPK5 and early-onset autosomal dominant Alzheimer disease: As a component of the MAPK signaling cascade, MK5 has been implicated in various neurological disorders, including Alzheimer's disease [28], Parkinson's disease [29] and autoimmune encephalomyelitis [30].